WAY-388264-A

Modify Date: 2024-02-04 17:41:23

WAY-388264-A Structure
WAY-388264-A structure
Common Name WAY-388264-A
CAS Number 393129-91-4 Molecular Weight 296.17
Density N/A Boiling Point N/A
Molecular Formula C11H14BrN5 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of WAY-388264-A


5-HT2B antagonist-1 is an orally active 5-HT2B receptor antagonist with an IC50 value of 33.4 nM. 5-HT2B antagonist-1 can be used in studies of diseases characterized by 5-HT2B receptor signaling, such as hepatocellular carcinoma, cardiovascular disease or gastrointestinal disease[1][2].

 Names

Name 5-HT2B antagonist-1

 WAY-388264-A Biological Activity

Description 5-HT2B antagonist-1 is an orally active 5-HT2B receptor antagonist with an IC50 value of 33.4 nM. 5-HT2B antagonist-1 can be used in studies of diseases characterized by 5-HT2B receptor signaling, such as hepatocellular carcinoma, cardiovascular disease or gastrointestinal disease[1][2].
Related Catalog
Target

5-HT2B Receptor:33.4 nM (IC50)

In Vitro 5-HT2B antagonist-1 (compound 5g) has some sodium channel binding activity with IC50 values in the range of 12.6 to 57.5 μM[1]. 5-HT2B antagonist-1 (coumpound 1-e) inhibits 5-HT2B receptor activity by less than 50% at 1 μM in CHO-K1 cell lines[3].
In Vivo 5-HT2B antagonist-1 (compound 15) (oral gavage, 30 mg/kg) can reduce visceral hypersensitivity significantly in irritable bowel syndrome (IBS) rats[2].
References

[1]. Xiang Ma, et al. Synthesis and in vitro evaluation of 2,4-diamino-1,3,5-triazine derivatives as neuronal voltage-gated sodium channel blockers. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5644

[2]. Yu Zhou, et al. Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome. J Med Chem. 2016 Jan 28;59(2):707-20.

[3]. Huang Niu, et al. 5-HT2B Antagonists. WO2015158214

 Chemical & Physical Properties

Molecular Formula C11H14BrN5
Molecular Weight 296.17
Storage condition 2-8°C